Agarwal, RajivHauske, Sibylle JennyWheeler, David C.Doi, KentElsaesser, AmelieRitter, IvanaSteubl, DominikWanner, Christoph2022-05-122022-05-122022Agarwal, R., Hauske, S. J., Wheeler, D. C., Doi, K., Elsaesser, A., Ritter, I., Steubl, D., & Wanner, C. (2022). Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in >15 000 individuals. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.146941463-1326https://hdl.handle.net/1805/28964enPublisher Policyacute kidney injurySGLT2 inhibitorkidney diseaseEmpagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in >15 000 individualsArticle